OLIGOMER-DIARYLPIPERAZIN-KONJUGATE

Patent europeic · EP2249872 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2249872
Numer da la dumonda
EP09704271
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
22-01-2009
Publitgà
17-11-2010
Concedì
22-03-2017
Stritgà
31-01-2018
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 47/60 (2017.01)
A61P 25/04 (2006.01)
Prioritad
US 62330 25.01.2008
Dumonda PCT
PCT/US2009/000475 22.01.2009
Publicaziun PCT
WO2009/094209 30.07.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-08-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.08.2018

  2. 22-03-2017

    Concedì

    Published in Swissreg on 22.03.2017

Partidas

Possessur

Nektar Therapeutics

455 Mission Bay Boulevard South Suite 100, San Francisco CA 94158, US

Inventur

REN, Zhongxu

Foster City, CA 94404, US

RIGGS-SAUTHIER, Jennifer

San Francisco, CA 94158, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.